“What this means for patients is that thiazides remain an important option in the toolkit for preventing kidney stone recurrence,” says Ryan S. Hsi, MD, FACS.
Researchers discovered that SGLT2i could help lower the risks of serious kidney and respiratory issues, including end-stage renal disease (ESRD), obstructive airway disease (OAD), and pneumonia.
Stone Clear provides a non-invasive option for managing post-lithotripsy kidney stone fragments, reducing complications and repeat procedures. Ultrasonic propulsion significantly extends time to ...